IVM

InterWest Venture Management Portfolio holdings

AUM $20.6M
This Quarter Return
+15.93%
1 Year Return
+48.5%
3 Year Return
-59.65%
5 Year Return
-75.84%
10 Year Return
–
AUM
$470M
AUM Growth
+$470M
Cap. Flow
-$4.15M
Cap. Flow %
-0.88%
Top 10 Hldgs %
99.79%
Holding
14
New
–
Increased
–
Reduced
1
Closed
2

Top Buys

No buys this quarter

Top Sells

1
OCRX
Ocera Therapeutics, Inc.
OCRX
$2.62M
2
XENE icon
Xenon Pharmaceuticals
XENE
$1.24M
3
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$285K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TSRO
1
DELISTED
TESARO, Inc.
TSRO
$311M 66.12%
2,021,403
– –
GKOS icon
2
Glaukos
GKOS
$5.39B
$52.2M 11.11%
1,018,362
– –
HIND
3
Vyome Holdings, Inc. Common Stock
HIND
$225M
$26.2M 5.58%
2,453,338
– –
MGNX icon
4
MacroGenics
MGNX
$110M
$20M 4.25%
1,074,316
– –
EIGR
5
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$18.3M 3.89%
1,599,592
– –
CDTX icon
6
Cidara Therapeutics
CDTX
$1.62B
$10.6M 2.25%
1,356,813
– –
AGTC
7
DELISTED
Applied Genetic Technologies Corporation
AGTC
$10M 2.13%
1,452,216
– –
PRTK
8
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$9.86M 2.1%
512,366
– –
IVTY
9
DELISTED
Invuity, Inc
IVTY
$8.59M 1.83%
1,080,272
– –
KALV icon
10
KalVista Pharmaceuticals
KALV
$719M
$2.58M 0.55%
329,942
– –
MEIP icon
11
MEI Pharma
MEIP
$159M
$940K 0.2%
580,401
– –
XENE icon
12
Xenon Pharmaceuticals
XENE
$3.03B
$33K 0.01%
8,293
-311,768
-97% -$1.24M
RETA
13
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-13,058
Closed -$285K
OCRX
14
DELISTED
Ocera Therapeutics, Inc.
OCRX
– –
-1,248,064
Closed -$2.62M